Αποτελέσματα Αναζήτησης
Methods: We conducted a systematic review to define the best therapies for actinic cheilitis in clinical response and recurrences. Results: We first identified 444 papers, and 49 were finally considered, including 789 patients and 843
31 Ιουλ 2023 · Providers in dermatology, dentistry, ENT, and primary care must be aware of actinic cheilitis as a premalignant lesion. They should have a low threshold to biopsy persistent lesions on the lips, especially if the patient has fair skin, a history of sun exposure, or a history of skin cancer.
14 Απρ 2021 · Actinic cheilitis (AC) is a chronic inflammation that affects more frequently to the lower lip and is considered as a potentially malignant disorder that could develop in to squamous cell...
1 Ιουν 2020 · We therefore recently put forth a proposal for cheilitis classification, defining three groups of cheilitis based on duration and etiology: mainly reversible cheilitis, mainly irreversible...
4 Ιουλ 2021 · In this systematic review, we tried to identify the best therapies of actinic cheilitis regarding safety, efficacy, recurrences, and the potential to progress to skin cancer. The therapeutic approach comprised invasive and topical treatments.
4 Ιουλ 2021 · PDF | Actinic cheilitis is a premalignant condition that may evolve to squamous cell carcinoma. A consensus on its management has not been established,... | Find, read and cite all the...
30 Νοε 2020 · Actinic cheilitis is a premalignant condition that can progress to squamous cell carcinoma with a higher propensity for metastasis than cutaneous squamous cell carcinoma. Optimal treatment for actinic cheilitis has not been established, and evidence-based estimates of clinical cure in the dermatology literature are limited.
